A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/55 (2006.01) A61K 31/438 (2006.01) A61K 31/5513 (2006.01) A61K 31/5517 (2006.01)
Patent
CA 2329916
This application discloses a method of treating cardiac ventricular arrhythmias and repolarization abnormalities associated with long QT syndrome and/or congestive heart failure comprising the administration of an agonist of the slowly activating cardiac delayed rectifier potassium current (IKs).
La présente invention concerne un traitement contre les arhytmies ventriculaires et les anomalies de repolarisation associées au syndrome de l'intervalle Q-T long et/ou à l'insuffisance cardiaque globale. Ce traitement consiste en l'administration d'un agoniste activation lente du courant cardiaque du potassium du redresseur temporisé (I¿Ks?).
Jurkiewicz Nancy K.
Salata Joseph J.
Sanguinetti Michael C.
Wang Jixin
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Potassium channel agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potassium channel agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potassium channel agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2001893